ArticleSchizophrenia (Heidelberg, Germany)2025
Salience network segregation and symptom profiles in psychosis risk subgroups among youth and early adults.
Article in Schizophrenia (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multimodal EEG-MRI Neuroimaging in Schizophrenia-A Systematic and Mechanistic Review.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding neurobiological similarities among individuals with psychosis risk symptoms can improve early identification and intervention strategies. We aimed to (i) identify neurobiologically similar psychosis risk subgroups by integrating resting-state functional connectivity and psychosis risk symptom data and (ii) discern discriminating symptom profiles and brain connectivity patterns in the identified sub-groups. Our sample (N = 922) was extracted from the Philadelphia Neurodevelopmental Cohort, a community group of individuals aged 12-21 years, with fMRI and self-reported psychopathology data. Analyses were conducted separately for youth and early adults. We constructed a two-layer network using pair-wise similarity distances between participants based on resting-state fMRI and psychosis risk symptoms measured with the PRIME screen. We then performed community detection via a multiplex stochastic block model to identify subject clusters. We identified 2 blocks or communities for both the youth (n = 458 and 179) and early adult (n = 173 and 112) groups. Connection parameter estimates of the neuroimaging layer were nearly identical between blocks for both age groups whereas there was significant variation for the symptom layer. Psychopathology symptom and brain system segregation profiles were consistent across age groups. The youth block (n = 458) with higher salience network segregation values had higher mean psychosis risk symptom scores while the early adult block (n = 173) with lower salience network segregation had higher mean psychosis risk symptom scores. By integrating global similarities in brain connectivity and psychosis risk symptoms, we identified distinct subgroups. These groups exhibit different symptom profiles and network segregation in youth and early adults, suggesting variations in developmental paths for psychosis spectrum.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.